ForteBio is now part of the Sartorius group. Click here for more

Resources Search

Filter By:

Search Results

Results 21 - 30 of 835

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

Meng Yuan, et al., March 2020 The outbreak of COVID-19, which is caused by SARS-CoV-2 virus, continues to spread globally, but there is currently very little understanding of the epitopes on the…


Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls, et al, pii: S0092-8674(20)30262-2 Cell March 2020 Read More


A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein

M. Gordon Joyce, et al, March 2020 SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease—COVID-19— within several months of its initial identification. Comparable…


A human monoclonal antibody blocking SARS-CoV-2 infection

Chunyan Wang, et al., March 2020 Read More


Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian, et al., 9(1): 382–385, Emerg Microbes Infect. 2020 The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including…


Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp, et al., Vol. 367, Issue 6483, pp. 1260-1263 , Science  13 Mar 2020 Read More


Rapid, at-line AAV Virus Titer Assay

ForteBio has developed a quick, high-throughput, and robust AAV2 capsid quantification method, capable of virus titer determination in samples along the purification process.


We use cookies to personalize content and improve your browsing experience.

We also use analytics & advertising services. To opt-out click for more information.